VentriPoint Diagnostics (CVE:VPT) Shares Down 4.3% – Should You Sell?

VentriPoint Diagnostics Ltd. (CVE:VPT)’s share price dropped 4.3% during mid-day trading on Wednesday . The company traded as low as C$0.11 and last traded at C$0.11. Approximately 182,422 shares traded hands during mid-day trading, a decline of 4% from the average daily volume of 189,112 shares. The stock had previously closed at C$0.12.

VentriPoint Diagnostics Trading Down 4.3%

The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56. The firm’s 50 day simple moving average is C$0.13 and its 200-day simple moving average is C$0.13. The company has a market capitalization of C$17.84 million, a PE ratio of -3.40 and a beta of 0.39.

About VentriPoint Diagnostics

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.